Pharmaids Pharmaceuticals Ltd — Board Meeting, 23-05-2025: Board Meeting

Pharmaids Pharmaceuticals has announced a board meeting on which the audited standalone and consolidated financial results for the quarter and half-year ending March 31, 2025, were approved. The audit report from M/s PPKG & Co, statutory auditors, expressed an unmodified opinion, confirming the financial statements' accuracy and fairness. This approval reflects the company’s compliance and readiness to share its financial performance with stakeholders, reinforcing transparency and accountability ahead.